Status:
COMPLETED
Comparison of Motor and Sensory Response With Interstim Stimulation
Lead Sponsor:
University of California, Irvine
Conditions:
Overactive Bladder
Urgency-Frequency
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Sacral nerve stimulation (SNS) implantation is a minimally invasive procedure which has current FDA approval for urinary urge incontinence, urgency-frequency syndrome and non-obstructive urinary reten...
Detailed Description
SNS involves a two-stage procedure. The initial phase is considered the test stimulation period where the patient is allowed to evaluate whether or not the therapy is effective in controlling her symp...
Eligibility Criteria
Inclusion
- You are eligible to participate in this study if:
- you are at least 18 years of age or older
- you have the capacity to give informed consent
- you are currently implanted with a functioning Interstim device for the treatment of urge urinary leakage or overactive bladder
Exclusion
- You are not eligible to participate in this study if:
- you do not meet the inclusion criteria and/or are not able to fully empty your bladder
- you have a history of an underlying neurologic disorder
- you are currently pregnant, or have an active urinary tract or vaginal infection
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00943904
Start Date
July 1 2009
End Date
February 1 2012
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCI Women's Healthcare
Orange, California, United States, 92868